Accelerate Diagnostics, Inc short interest in 2025
In 2025, Accelerate Diagnostics, Inc's disclosed short interest ran from 1.60% of shares outstanding on 15 Jan 2025 to 1.18% on 30 Apr 2025, a change of -0.42 percentage points. The year's high was 1.85% on 31 Jan 2025 and its low 1.16% on 15 Apr 2025, averaging 1.56% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.46 days on 14 Feb 2025. Full history: Accelerate Diagnostics, Inc.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2025 in figures
- Start of year
- 1.60% (15 Jan 2025)
- End of year
- 1.18% (30 Apr 2025)
- Change
- -0.42 pp
- High
- 1.85% (31 Jan 2025)
- Low
- 1.16% (15 Apr 2025)
- Average
- 1.56%
- Highest days to cover
- 24.46 (14 Feb 2025)
- SEC filings marked
- 3
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 1.60% | 9.10 | results (8-K) |
| 31 Jan 2025 | 1.85% | 10.13 | |
| 14 Feb 2025 | 1.78% | 24.46 | |
| 28 Feb 2025 | 1.76% | 18.99 | |
| 14 Mar 2025 | 1.70% | 21.55 | |
| 31 Mar 2025 | 1.42% | 5.00 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 1.16% | 4.26 | |
| 30 Apr 2025 | 1.18% | 14.17 |
See also: Accelerate Diagnostics, Inc's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.